Pharmaceutical patents in Europe / / Bengt Domeij.
The pharmaceutical industry and patent legislation are inextricably linked. Pharmaceutical companies could not exist without some guarantee that they can recoup the cost of developing a new product. European patent law offers this opportunity, as it allows companies to exclude competition for a spec...
Saved in:
Superior document: | Stockholm studies in law, 3 |
---|---|
VerfasserIn: | |
Place / Publishing House: | Leiden;, Boston : : Brill | Nijhoff,, 2000. |
Year of Publication: | 2000 |
Language: | English |
Series: | Stockholm Studies in Law ;
3. |
Physical Description: | 1 online resource. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993583286204498 |
---|---|
ctrlnum |
(CKB)5450000000014977 (OCoLC)842448267 (nllekb)BRILL9789004481473 (MiAaPQ)EBC6802975 (Au-PeEL)EBL6802975 (EXLCZ)995450000000014977 |
collection |
bib_alma |
record_format |
marc |
spelling |
Domeij, Bengt author. Pharmaceutical patents in Europe / Bengt Domeij. Leiden; Boston : Brill | Nijhoff, 2000. 1 online resource. text txt rdacontent computer c rdamedia online resource rdacarrier Stockholm studies in law, 1387-6023 ; 3 Description based on print version record. The pharmaceutical industry and patent legislation are inextricably linked. Pharmaceutical companies could not exist without some guarantee that they can recoup the cost of developing a new product. European patent law offers this opportunity, as it allows companies to exclude competition for a specific product for a fixed time scale. In Pharmaceutical Patents in Europe the current legal patent situation is examined by a detailed analysis of case law from the European Patent Office (EPO), the international body created with the signing of the European Patent Convention (EPC). Aspects of European patent law not primarily regulated in the EPC, for example Supplementary Protection Certificates and infringement matters, are examined in the setting provided by EC law and domestic laws of European states. This book is written for the reader who understands the main characteristics of patent law and is looking for a practitioner's text on the European pharmaceutical patent law scene. Moreover, the author's remarks can help all readers to look at the field with fresh eyes. Includes bibliographical references and index. Acknowledgements. Foreword. Abbreviations. 1. Industrial Applicability. 2. Sufficiency of Disclosure. 3. The Claims. 4. Novelty. 5. New Medical Uses of Known Compounds. 6. Inventive step. 7. Supplementary Patent Protection. 8. Patent Infringement. 9. References. 10. Index. Biotechnology. Drugs Europe Patents. Octrooirecht. 90-411-1348-7 9139006018 Stockholm Studies in Law ; 3. |
language |
English |
format |
eBook |
author |
Domeij, Bengt |
spellingShingle |
Domeij, Bengt Pharmaceutical patents in Europe / Stockholm studies in law, Acknowledgements. Foreword. Abbreviations. 1. Industrial Applicability. 2. Sufficiency of Disclosure. 3. The Claims. 4. Novelty. 5. New Medical Uses of Known Compounds. 6. Inventive step. 7. Supplementary Patent Protection. 8. Patent Infringement. 9. References. 10. Index. |
author_facet |
Domeij, Bengt |
author_variant |
b d bd |
author_role |
VerfasserIn |
author_sort |
Domeij, Bengt |
title |
Pharmaceutical patents in Europe / |
title_full |
Pharmaceutical patents in Europe / Bengt Domeij. |
title_fullStr |
Pharmaceutical patents in Europe / Bengt Domeij. |
title_full_unstemmed |
Pharmaceutical patents in Europe / Bengt Domeij. |
title_auth |
Pharmaceutical patents in Europe / |
title_new |
Pharmaceutical patents in Europe / |
title_sort |
pharmaceutical patents in europe / |
series |
Stockholm studies in law, |
series2 |
Stockholm studies in law, |
publisher |
Brill | Nijhoff, |
publishDate |
2000 |
physical |
1 online resource. |
contents |
Acknowledgements. Foreword. Abbreviations. 1. Industrial Applicability. 2. Sufficiency of Disclosure. 3. The Claims. 4. Novelty. 5. New Medical Uses of Known Compounds. 6. Inventive step. 7. Supplementary Patent Protection. 8. Patent Infringement. 9. References. 10. Index. |
isbn |
90-04-48147-8 90-411-1348-7 9139006018 |
issn |
1387-6023 ; |
callnumber-first |
K - Law |
callnumber-label |
KJC2751 |
callnumber-sort |
KJC 42751 M44 |
genre_facet |
Patents. |
geographic_facet |
Europe |
illustrated |
Not Illustrated |
dewey-hundreds |
300 - Social sciences |
dewey-tens |
340 - Law |
dewey-ones |
346 - Private law |
dewey-full |
346.404/86 |
dewey-sort |
3346.404 286 |
dewey-raw |
346.404/86 |
dewey-search |
346.404/86 |
oclc_num |
842448267 |
work_keys_str_mv |
AT domeijbengt pharmaceuticalpatentsineurope |
status_str |
n |
ids_txt_mv |
(CKB)5450000000014977 (OCoLC)842448267 (nllekb)BRILL9789004481473 (MiAaPQ)EBC6802975 (Au-PeEL)EBL6802975 (EXLCZ)995450000000014977 |
hierarchy_parent_title |
Stockholm studies in law, 3 |
hierarchy_sequence |
3. |
is_hierarchy_title |
Pharmaceutical patents in Europe / |
container_title |
Stockholm studies in law, 3 |
_version_ |
1796652886661267457 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02861nam a22005058i 4500</leader><controlfield tag="001">993583286204498</controlfield><controlfield tag="005">20230422035649.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr#un####uuuua</controlfield><controlfield tag="008">200716s2000 ne ob 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 00035748</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">90-04-48147-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1163/9789004481473</subfield><subfield code="2">DOI</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5450000000014977</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)842448267</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(nllekb)BRILL9789004481473</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)EBC6802975</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL6802975</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995450000000014977</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NL-LeKB</subfield><subfield code="c">NL-LeKB</subfield><subfield code="e">rda</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">e------</subfield></datafield><datafield tag="050" ind1="0" ind2="0"><subfield code="a">KJC2751.M44</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">LBDK</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">LAW</subfield><subfield code="x">014000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">LAW</subfield><subfield code="x">051000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="0" ind2="0"><subfield code="a">346.404/86</subfield><subfield code="2">21</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Domeij, Bengt</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical patents in Europe /</subfield><subfield code="c">Bengt Domeij.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Leiden;</subfield><subfield code="a">Boston :</subfield><subfield code="b">Brill | Nijhoff,</subfield><subfield code="c">2000.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Stockholm studies in law,</subfield><subfield code="x">1387-6023 ;</subfield><subfield code="v">3</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The pharmaceutical industry and patent legislation are inextricably linked. Pharmaceutical companies could not exist without some guarantee that they can recoup the cost of developing a new product. European patent law offers this opportunity, as it allows companies to exclude competition for a specific product for a fixed time scale. In Pharmaceutical Patents in Europe the current legal patent situation is examined by a detailed analysis of case law from the European Patent Office (EPO), the international body created with the signing of the European Patent Convention (EPC). Aspects of European patent law not primarily regulated in the EPC, for example Supplementary Protection Certificates and infringement matters, are examined in the setting provided by EC law and domestic laws of European states. This book is written for the reader who understands the main characteristics of patent law and is looking for a practitioner's text on the European pharmaceutical patent law scene. Moreover, the author's remarks can help all readers to look at the field with fresh eyes.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Acknowledgements. Foreword. Abbreviations. 1. Industrial Applicability. 2. Sufficiency of Disclosure. 3. The Claims. 4. Novelty. 5. New Medical Uses of Known Compounds. 6. Inventive step. 7. Supplementary Patent Protection. 8. Patent Infringement. 9. References. 10. Index.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biotechnology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="z">Europe</subfield><subfield code="x">Patents.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Octrooirecht.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="z">Europe</subfield><subfield code="v">Patents.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">90-411-1348-7</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">9139006018</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Stockholm Studies in Law ;</subfield><subfield code="v">3.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-24 02:43:07 Europe/Vienna</subfield><subfield code="d">00</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2021-01-30 22:19:47 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">Brill</subfield><subfield code="P">EBA Brill All</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5343601480004498&Force_direct=true</subfield><subfield code="Z">5343601480004498</subfield><subfield code="b">Available</subfield><subfield code="8">5343601480004498</subfield></datafield></record></collection> |